Franklin Resources, Inc. 13D and 13G filings for Contineum Therapeutics, Inc. Class A Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-29 10:38 am Purchase | 2025-12-31 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | FRANKLIN RESOURCES INC BEN | 1,879,367 6.200% | 223,819 (+13.52%) | Filing |
| 2025-11-04 10:38 am Sale | 2025-09-30 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | FRANKLIN RESOURCES INC BEN | 1,655,548 7.700% | -43,277 (-2.55%) | Filing |
| 2025-08-05 11:22 am Purchase | 2025-06-30 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | FRANKLIN RESOURCES INC BEN | 1,698,825 8.900% | 251,275 (+17.36%) | Filing |
| 2024-10-31 12:46 pm Purchase | 2024-09-30 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | FRANKLIN RESOURCES INC BEN | 1,447,550 7.600% | 1,447,550 (New Position) | Filing |